|Study Description:||The goal of this clinical research study to find the highest tolerated dose of |
anastrozole alone or in combination with either everolimus (Afinitor),
sorafenib (Nexavar), erlotinib (Tarceva), fulvestrant (Faslodex), or
bevacizumab (Avastin) that can be given to patients with advanced cancer. The
safety of these drug combinations will also be studied.